Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MDA-MB-231 | 0 | uM | 10 | 156.25 | 67.09 | 237.00 | 231.00 | 1.0260 | 1.0290 | |
| MDA-MB-231 | 17-AAG | 1 | uM | 10 | 156.25 | 67.09 | 184.00 | 231.00 | 0.7965 | 0.7605 |
| MDA-MB-231 | Linsitinib | 10 | uM | 10 | 156.25 | 67.09 | 212.00 | 231.00 | 0.9178 | 0.9060 |
| MDA-MB-231 | 17-AAG | 0.1 | uM | 10 | 156.25 | 67.09 | 371.00 | 231.00 | 1.6061 | 1.6085 |
| MDA-MB-231 | Lapatinib | 0.01 | uM | 10 | 156.25 | 67.09 | 452.00 | 231.00 | 1.9567 | 1.9139 |
| MDA-MB-231 | 17-AAG | 0.031623 | uM | 10 | 156.25 | 67.09 | 314.00 | 231.00 | 1.3593 | 1.3756 |
| MDA-MB-231 | Lapatinib | 0.1 | uM | 10 | 156.25 | 67.09 | 395.00 | 231.00 | 1.7100 | 1.7018 |
| MDA-MB-231 | Lapatinib | 0.031623 | uM | 10 | 156.25 | 67.09 | 501.00 | 231.00 | 2.1688 | 2.0869 |
| MDA-MB-231 | Linsitinib | 3.1623 | uM | 10 | 156.25 | 67.09 | 319.00 | 231.00 | 1.3810 | 1.3967 |
| MDA-MB-231 | 0 | uM | 10 | 156.25 | 67.09 | 413.00 | 231.00 | 1.7879 | 1.7701 | |
| MDA-MB-231 | Erlotinib | 0.1 | uM | 10 | 156.25 | 67.09 | 449.00 | 231.00 | 1.9437 | 1.9030 |
| MDA-MB-231 | Linsitinib | 0.31623 | uM | 10 | 156.25 | 67.09 | 331.00 | 231.00 | 1.4329 | 1.4469 |
| MDA-MB-231 | Linsitinib | 0.1 | uM | 10 | 156.25 | 67.09 | 349.00 | 231.00 | 1.5108 | 1.5206 |
| MDA-MB-231 | Erlotinib | 1 | uM | 10 | 156.25 | 67.09 | 296.00 | 231.00 | 1.2814 | 1.2983 |
| MDA-MB-231 | Linsitinib | 19.9526 | uM | 10 | 156.25 | 67.09 | 156.00 | 231.00 | 0.6753 | 0.6049 |
| MDA-MB-231 | Erlotinib | 0.031623 | uM | 10 | 156.25 | 67.09 | 229.00 | 231.00 | 0.9913 | 0.9903 |
| MDA-MB-231 | 0 | uM | 10 | 156.25 | 67.09 | 321.00 | 231.00 | 1.3896 | 1.4051 | |
| MDA-MB-231 | 17-AAG | 3.1623 | uM | 10 | 156.25 | 67.09 | 71.00 | 231.00 | 0.3074 | 0.0323 |
| MDA-MB-231 | 0 | uM | 10 | 156.25 | 67.09 | 160.00 | 231.00 | 0.6926 | 0.6279 | |
| MDA-MB-231 | 0 | uM | 10 | 156.25 | 67.09 | 214.00 | 231.00 | 0.9264 | 0.9161 | |
| MDA-MB-231 | 17-AAG | 10 | uM | 10 | 156.25 | 67.09 | 53.00 | 231.00 | 0.2294 | -0.1238 |
| MDA-MB-231 | 17-AAG | 0.0016596 | uM | 10 | 156.25 | 67.09 | 361.00 | 231.00 | 1.5628 | 1.5688 |
| MDA-MB-231 | Lapatinib | 0.0033113 | uM | 10 | 156.25 | 67.09 | 237.00 | 231.00 | 1.0260 | 1.0290 |
| MDA-MB-231 | Erlotinib | 0.01 | uM | 10 | 156.25 | 67.09 | 230.00 | 231.00 | 0.9957 | 0.9951 |
| MDA-MB-231 | 0 | uM | 10 | 156.25 | 67.09 | 278.00 | 231.00 | 1.2035 | 1.2188 |